West Paces Advisors’s Bio-Techne TECH Stock Holding History

West Paces Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12	Closed	-$860	–	574
2024 Q2	$860	Hold	12	–	–	﹤0.01%	499
2024 Q1	$845	Sell	12 -122	-91%	-$8.73K	﹤0.01%	516
2023 Q4	$10.3K	Buy	+134	New	+$8.83K	﹤0.01%	358

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

West Paces Advisors's TECH Position: Q3 2024 in Review

West Paces Advisors sold out of Bio-Techne (TECH) in Q3 2024, closing a stake of 12 shares — an estimated $860 sold.

West Paces Advisors first reported a position in TECH in Q4 2023 and held it in 3 quarters. The position peaked at $10.3K in Q4 2023. 562 funds tracked by Wall St. Rank hold TECH as of Q3 2024.

West Paces Advisors reported no remaining Bio-Techne position as of Q3 2024 after selling out during the quarter.
West Paces Advisors sold 12 Bio-Techne shares in Q3 2024, an estimated $860.
West Paces Advisors first reported a position in Bio-Techne in Q4 2023 and held it in 3 quarters.
West Paces Advisors's Bio-Techne position peaked at $10.3K in Q4 2023.
562 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2024.

Based on West Paces Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.